Reproducibility of segmentation error correction in age-related macular degeneration: Stratus versus Cirrus OCT

British Journal of Ophthalmology

Volumn 96, Issue 2, 2012, Pages 271-275

  Krebs, Ilse ^a,b   Hagen, Stefan ^a,b   Smretschnig, Eva ^a   Womastek, Irene ^c   Brannath, Werner ^c   Binder, Susanne ^a,b  

^a LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

^b KRANKENANSTALT RUDOLFSTIFTUNG   (Austria)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ADULT; AGED; ALGORITHM; ARTICLE; AUTOANALYSIS; CENTRAL RETINAL THICKNESS; COMPUTER PROGRAM; CONTROLLED STUDY; DISTANCE ACUITY; EXUDATIVE MACULAR DEGENERATION; HUMAN; IMAGE QUALITY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEASUREMENT ERROR; MEDICAL PERSONNEL; OPHTHALMOLOGIST; OPTICAL COHERENCE TOMOGRAPHY; PRIORITY JOURNAL; PROFESSIONAL KNOWLEDGE; PROSPECTIVE STUDY; REPRODUCIBILITY; RESIDENT; RETINA MACULA AGE RELATED DEGENERATION; SEGMENTATION ERROR CORRECTION; VISUAL SYSTEM PARAMETERS; WORK EXPERIENCE;

AGED; AGED, 80 AND OVER; ALGORITHMS; HUMANS; MACULAR DEGENERATION; MIDDLE AGED; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RETINA; SENSORY THRESHOLDS; TOMOGRAPHY, OPTICAL COHERENCE; VISUAL ACUITY;

EID: 84856050205     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2010.194662     Document Type: Article

References (17)

1. Rosenfeld PJ, Brown DM, Heier JS, et al MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006;355:1419-31. (Pubitemid 44511557)
2. Kaiser PK, Brown DM, Zhang K, et al. Ranibizumab for predominantly classic neovascular age-related macular degeneration: subgroup analysis of first-year ANCHOR results. Am J Ophthalmol 2007;144:850-7.
3. Fung AE, Lalwani GA, Rosenfeld PJ, et al. An optical coherence tomography-guided, variable dosing regimen with intravitreal ranibizumab (Lucentis) for neovascular age-related macular degeneration. Am J Ophthalmol 2007;143:566-83.
4. Krebs I, Ansari-Shahrezaei S, Goll A, et al. Activity of neovascular lesions treated with bevacizumab: comparison between optical coherence tomography and fluorescein angiography. Graefes Arch Clin Exp Ophthalmol 2008;246:811-15.
5. Malamos P, Sacu S, Georgopoulos M, et al. Correlation of high-definition optical coherence tomography and fluorescein angiography imaging in neovascular macular degeneration. Invest Ophthalmol Vis Sci 2009;50:4926-33.
6. Sadda SR, Wu Z, Walsh AC, et al. Errors in retinal thickness measurements obtained by optical coherence tomography. Ophthalmology 2006;113:285-93. (Pubitemid 43170778)
7. Ray R, Stinnett SS, Jaffe GJ. Evaluation of image artifact produced by optical coherence tomography of retinal pathology. Am J Ophthalmol 2005;139:18-29. (Pubitemid 40094836)
8. Krebs I, Haas P, Zeiler F, et al. Optical coherence tomography: limits of the retinal-mapping program in age-related macular degeneration. Br J Ophthalmol 2008;92:933-5. (Pubitemid 351969673)
9. Krebs I, Falkner-Radler C, Hagen S, et al. Quality of the threshold algorithm in age-related macular degeneration: Stratus versus Cirrus OCT. Invest Ophthalmol Vis Sci 2009;50:995-1000.
10. Friedman M. The use of ranks to avoid the assumption of normality implicit in the analysis of variance. J Am Stat Assoc 1937;32:675-701.
11. Ahlers C, Simader C, Geitzenauer W, et al. Automatic segmentation in three-dimensional analysis of fibrovascular pigmentepithelial detachment using high-definition optical coherence tomography. Br J Ophthalmol 2008;92:197-203. (Pubitemid 351224094)
12. Holz FG, Jorzik J, Schutt F, et al. Agreement among ophthalmologists in evaluating fluorescein angiograms in patients with neovascular age-related macular degeneration for photodynamic therapy eligibility (FLAP-study). Ophthalmology 2003;110:400-5 (Pubitemid 36184347)
13. Costa RA, Calucci D, Skaf M, et al. Optical coherence tomography 3: Automatic delineation of the outer neural retinal boundary and its influence on retinal thickness measurements. Invest Ophthalmol Vis Sci 2004;45:2399-406. (Pubitemid 38902615)
14. Browning DJ, Glassman AR, Aiello LP, et al Diabetic Retinopathy Clinical Research Network. Optical coherence tomography measurements and analysis methods in optical coherence tomography studies of diabetic macular edema. Ophthalmology 2008;115:1366-71.
15. Tatlipinar S, Shah SM, Campochiaro PA, et al. Intraobserver repeatability of automated versus adjusted optical coherence tomography measurements in patients with neovascular age-related macular degeneration. Ophthalmologica 2007;221:227-32. (Pubitemid 46956799)
16. Sadda SR, Joeres S, Wu Z, et al. Error correction and quantitative subanalysis of optical coherence tomography data using computer-assisted grading. Invest Ophthalmol Vis Sci 2007;48:839-48. (Pubitemid 351260721)
17. Keane PA, Liakopoulos S, Jivrajka RV, et al. Evaluation of optical coherence tomography retinal thickness parameters for use in clinical trials for neovascular age-related macular degeneration. Invest Ophthalmol Vis Sci 2009;50:3378-85.